Skip to main content

and
  1. No Access

    Article

    The 30-day readmission rate in neurosurgery—a useful indicator for quality assessment?

    A shift in how we evaluate healthcare outcomes has driven the introduction of quality indicators as potential parameters to evaluate value-based healthcare delivery. So far, only few studies have been performe...

    Stephanie Schipmann, Eric Suero Molina, Julia Windheuser in Acta Neurochirurgica (2020)

  2. No Access

    Article

    The rise of quality indicators in neurosurgery: 30-day unplanned reoperation rate evaluated in 3760 patients—a single-center experience

    Quality indicators are emerging as tools to evaluate health care outcomes. Few studies have evaluated indicators suitable for neurosurgery so far. Among others, reoperation rate has been suggested as a possibl...

    Eric Suero Molina, Cheyenne Schildmacher, Justin Doods in Acta Neurochirurgica (2020)

  3. Article

    Open Access

    Leveraging the EHR4CR platform to support patient inclusion in academic studies: challenges and lessons learned

    The development of Electronic Health Records (EHRs) in hospitals offers the ability to reuse data from patient care activities for clinical research. EHR4CR is a European public-private partnership aiming to d...

    Yannick Girardeau, Justin Doods, Eric Zapletal in BMC Medical Research Methodology (2017)

  4. Article

    Open Access

    Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting

    Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate ...

    Philipp Bruland, Mark McGilchrist, Eric Zapletal in BMC Medical Research Methodology (2016)

  5. Article

    Open Access

    Efficiency and effectiveness evaluation of an automated multi-country patient count cohort system

    With the increase of clinical trial costs during the last decades, the design of feasibility studies has become an essential process to reduce avoidable and costly protocol amendments. This design includes tim...

    Iñaki Soto-Rey, Benjamin Trinczek, Yannick Girardeau in BMC Medical Research Methodology (2015)

  6. Article

    Open Access

    A European inventory of common electronic health record data elements for clinical trial feasibility

    Clinical studies are a necessity for new medications and therapies. Many studies, however, struggle to meet their recruitment numbers in time or have problems in meeting them at all. With increasing numbers of...

    Justin Doods, Florence Botteri, Martin Dugas, Fleur Fritz in Trials (2014)